Estrogen receptor beta signaling inhibits PDGF induced human airway smooth muscle proliferation. 2018

Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, USA.

Airway smooth muscle (ASM) cell hyperplasia driven by persistent inflammation is a hallmark feature of remodeling in asthma. Sex steroid signaling in the lungs is of considerable interest, given epidemiological data showing more asthma in pre-menopausal women and aging men. Our previous studies demonstrated that estrogen receptor (ER) expression increases in asthmatic human ASM; however, very limited data are available regarding differential roles of ERα vs. ERβ isoforms in human ASM cell proliferation. In this study, we evaluated the effect of selective ERα and ERβ modulators on platelet-derived growth factor (PDGF)-stimulated ASM proliferation and the mechanisms involved. Asthmatic and non-asthmatic primary human ASM cells were treated with PDGF, 17β-estradiol, ERα-agonist and/or ERβ-agonist and/or G-protein-coupled estrogen receptor 30 (GPR30/GPER) agonist and proliferation was measured using MTT and CyQuant assays followed by cell cycle analysis. Transfection of small interfering RNA (siRNA) ERα and ERβ significantly altered the human ASM proliferation. The specificity of siRNA transfection was confirmed by Western blot analysis. Gene and protein expression of cell cycle-related antigens (PCNA and Ki67) and C/EBP were measured by RT-PCR and Western analysis, along with cell signaling proteins. PDGF significantly increased ASM proliferation in non-asthmatic and asthmatic cells. Treatment with PPT showed no significant effect on PDGF-induced proliferation, whereas WAY interestingly suppressed proliferation via inhibition of ERK1/2, Akt, and p38 signaling. PDGF-induced gene expression of PCNA, Ki67 and C/EBP in human ASM was significantly lower in cells pre-treated with WAY. Furthermore, WAY also inhibited PDGF-activated PCNA, C/EBP, cyclin-D1, and cyclin-E. Overall, we demonstrate ER isoform-specific signaling in the context of ASM proliferation. Activation of ERβ can diminish remodeling in human ASM by inhibiting pro-proliferative signaling pathways, and may point to a novel perception for blunting airway remodeling.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D047628 Estrogen Receptor alpha One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA. ERalpha,Estradiol Receptor alpha,Estrogen Receptor 1,Estrogen Receptors alpha,Receptor alpha, Estrogen,Receptor alpha, Estradiol,alpha, Estradiol Receptor

Related Publications

Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
August 2015, Experimental cell research,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
July 2018, European journal of pharmacology,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
January 2015, International journal of clinical and experimental medicine,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
June 2017, Molecular medicine reports,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
March 1996, The American journal of physiology,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
May 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
January 2013, BioMed research international,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
February 2018, Molecular medicine reports,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
January 2022, Allergologia et immunopathologia,
Nilesh Sudhakar Ambhore, and Rathnavali Katragadda, and Rama Satyanarayana Raju Kalidhindi, and Michael A Thompson, and Christina M Pabelick, and Y S Prakash, and Venkatachalem Sathish
January 2020, Pharmacology,
Copied contents to your clipboard!